Medications and Drugs

GENERIC NAME: Isoniazid, INH

BRAND NAME: Nydrazid, Laniazid

DRUG CLASS AND MECHANISM: Isoniazid, or INH, is an anti-bacterial drug that has been used to prevent and to treat tuberculosis since 1952. Tuberculosis is an infectious diseased caused by a bacterium. Once the infection is acquired, it usually remains dormant in the lungs. Later, the infection may become active in the lungs and sometimes spreads throughout the body. Patients with a tuberculosis skin test that has recently become abnormal (demonstrating recent infection with tuberculosis) but a normal chest x-ray (demonstrating inactive infection) are given INH alone for 6-9 months. Patients with active infection on chest x-ray are given INH combined with other antituberculous drugs.

The mechanism of action of INH is not known, but it is thought to work through its effects on lipids (fats) and DNA within the tuberculosis bacterium. It is very selective for the tuberculosis bacteria, that is, it has few if any effects on other bacteria.

PRESCRIPTION: yes

GENERIC AVAILABLE: yes

PREPARATIONS: INH is available as 100 mg or 300 mg tablets and as a syrup (50 mg per teaspoonful).

STORAGE: Tablets and syrup should be stored at room temperature, 15-30°C (59-86°F).

PRESCRIBED FOR: INH is used to prevent active tuberculosis in persons who have an abnormal skin test for tuberculosis or in combination with other drugs for the treatment of active tuberculosis.

DOSING: INH is most commonly taken once daily. When used for the treatment of active tuberculosis, some physicians prefer using a high dose twice weekly. It is best to take INH on an empty stomach for maximum absorption into the body, but if it causes abdominal discomfort, it may be taken with food or with a non-aluminum antacid such as Tums or Titralac. (Aluminum-containing antacids bind to the INH in the intestine and prevent its absorption.)

DRUG INTERACTIONS: Antacids containing aluminum (e.g. Mylanta; Maalox, Gelusil; Amphojel; Alternagel) reduce the amount of INH that is absorbed from the intestine, and this can result in reduced blood levels and effect of INH. If aluminum-containing antacids must be taken, they should be taken at least one hour after the INH to prevent binding.

INH can increase the effectiveness of the blood thinner, warfarin (Coumadin) by interfering with the enzyme in the liver that eliminates warfarin.

INH can increase the effect of certain benzodiazepines, such as diazepam (Valium), triazolam (Halcion), and others, by interfering with the enzymes in the liver that eliminate benzodiazepines. This may result in excessive sedation.

Carbamazepine (Tegretol) taken at the same time as INH, can result in an increased risk of side effects from both carbamazepine and INH.

INH can decrease the rate at which the liver eliminates phenytoin (Dilantin), which can raise the blood levels and result in side effects of phenytoin.

Because rifampin can be toxic to the liver, the use of rifampin and INH together increases the risk of liver toxicity to a level that is greater than with either drug alone. .

PREGNANCY: INH has not been shown to cause birth defects in humans or animals; however, studies in rats and rabbits have shown that it may increase the risk of fetal death. Nevertheless, tuberculosis is a very serious infection, and many women have been treated with isoniazid during pregnancy with no problems in their infants. Ultimately, the physician and the pregnant patient must evaluate the risks and benefits of INH.

NURSING MOTHERS: INH is secreted into breast milk, however, it has not been reported to cause problems in nursing babies. Ultimately, the physician and the nursing mother must evaluate the risks and benefits of INH.

Report Problems to the Food and Drug Administration   You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Back to Medications Index